September 22, 2017, 4:05 pm

JUVÉDERM VOLLURE™ XC dermal filler New Jersey

Americans seeking to turn back the clock to a more youthful appearance how have another tool to rely on. The FDA recently approved a new Hyaluronic Acid Dermal Filler manufactured by Allergan. JUVÉDERM VOLLURE™ XC has available in Europe since 2013 (under the name Juvéderm® VOLIFT®) and is now be available to Americans over 21.


CALL TODAY 908-630-0007 EXT. 14



This innovative Dermal Filler is approved for “the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.” Clinical trials revealed that 59% of patients experienced significant improvements in smile lines around the mouth for up to 18 months. Satisfaction rates were good–with 82% of patients pleased with their results at 6 months, and 68% still satisfied at 8 months.

What makes this specific Dermal Filler product so exciting is that it requires fewer injection sessions and lasts up to 18 months. VYCROSS Technology is used to connect high and low molecular weight Hyaluronic Acid together through cross-linking to form a more connected gel. The product is substantial enough to fill depressions, but is gentle enough to move naturally with facial expressions.

Another benefit of JUVÉDERM VOLLURE™ XC is that this formula produces very minimal swelling, which means shorter recovery time. Side effects such as swelling, bruising, tenderness, lumps, redness, pain, discoloration, and itching were generally very mild and resolved within a week.

Like other JUVÉDERM products, VOLLURE™ XC includes Lidocaine as a numbing agent to guarantee patient comfort.


Back to Top

Tags: , , , , ,

Category: Dermal Fillers